When eligible , they were randomly assigned to undergo either the DASE protocol ( group A , 50 patients ) or the ADSE protocol ( group B , 50 patients ) when atropine ( 1.0 mg ) was first administered 3 min before dobutamine infusion followed by 0.5 mg increments ( maximum 1.0 mg ) thereafter .